Unicentric Castleman Disease: Causes, Symptoms, And Treatment

Unicentric Castleman disease is a rare non-cancerous condition that affects the lymph nodes in the body. It is characterized by the abnormal growth of cells in the lymphatic system. The exact cause of Unicentric Castleman disease is not well understood, but it is believed to involve an overactive immune system response to an unknown trigger. This can lead to the development of enlarged lymph nodes and other symptoms. While the condition is not considered hereditary, certain factors such as infections or autoimmune disorders may play a role in its development. Understanding the underlying causes of Unicentric Castleman disease is crucial for proper diagnosis and management.

What Are the Symptoms of Unicentric Castleman Disease

Unicentric Castleman disease can present with various symptoms, such as enlarged lymph nodes, fatigue, night sweats, and weight loss. Some patients may experience anemia, weakness, and nerve pain. This rare condition can also lead to fluid accumulation in the abdomen or legs, along with decreased appetite and overall discomfort. It is essential to consult a healthcare provider if experiencing persistent symptoms to receive a proper diagnosis and appropriate management.

Fatigue and weakness are common symptoms of Unicentric Castleman disease, often impacting daily activities and quality of life.
Enlarged lymph nodes, particularly in the neck, chest, or abdomen, can be a noticeable physical manifestation of the disease.
Night sweats may occur in individuals with Unicentric Castleman disease, leading to discomfort during sleep and disrupted rest.
Some patients may experience unintended weight loss as a symptom of Unicentric Castleman disease, often accompanied by decreased appetite.
Flulike symptoms such as fever, chills, and body aches can manifest in individuals with Unicentric Castleman disease, mimicking infectious illnesses.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Unicentric Castleman Disease

The exact cause of this condition is not fully understood, but it is believed to be related to an overactive immune response or viral infections. Certain risk factors, such as being infected with the human herpesvirus-8 (HHV-8) or having a weakened immune system, may predispose individuals to developing Unicentric Castleman disease. Genetic factors may also play a role in some cases. Research is ongoing to better understand the underlying causes of this disease and develop more effective treatments.

Viral infections, such as HIV or herpesvirus, can trigger Unicentric Castleman disease by stimulating abnormal immune responses.
Genetic factors may play a role in the development of Unicentric Castleman disease, although specific genetic mutations have not been definitively identified.
Overproduction of a protein called interleukin-6 (IL-6) by certain cells in the lymph nodes can contribute to the pathogenesis of Unicentric Castleman disease.
Autoimmune conditions, where the immune system mistakenly attacks the body's tissues, may lead to the development of Unicentric Castleman disease.

Types Of Unicentric Castleman Disease

Hyaline vascular Castleman disease is the most common type, characterized by small lymphoid follicles with penetrating vessels and hyalinized germinal centers. In contrast, the plasma cell variant exhibits prominent plasma cell infiltration within germinal centers. The mixed variant combines features of both hyaline vascular and plasma cell types. Understanding the distinct subtypes is crucial for accurate diagnosis and treatment planning for patients with Unicentric Castleman disease.

Hyaline-vascular type: This is the most common type of Unicentric Castleman disease, characterized by a hyaline-vascular appearance under the microscope.
Plasma cell type: Less common than the hyaline-vascular type, the plasma cell type is characterized by an abundance of plasma cells in the affected lymph node.
Mixed type: In some cases, a combination of features from both the hyaline-vascular and plasma cell types may be present in Unicentric Castleman disease.
Inflammatory type: This rare subtype of Unicentric Castleman disease is characterized by prominent inflammatory changes within the affected lymph node.

Risk Factors

While the exact cause of this condition is not fully understood, certain risk factors have been identified. Individuals with a weakened immune system, such as those living with HIV/AIDS, organ transplant recipients, or individuals on immunosuppressive therapy, are at higher risk of developing Unicentric Castleman disease. Additionally, there may be genetic predispositions that contribute to the development of this disorder. Further research is needed to better understand the underlying mechanisms and risk factors associated with Unicentric Castleman disease.

Being infected with human herpesvirus-8 (HHV-8) is a risk factor for Unicentric Castleman disease, a rare lymphoproliferative disorder.
Individuals who are immunocompromised, such as those with HIV/AIDS or undergoing organ transplantation, are at increased risk for developing Unicentric Castleman disease.
Young adults between the ages of 20 and 40 are more likely to be diagnosed with Unicentric Castleman disease compared to other age groups.
Genetic factors may play a role in the development of Unicentric Castleman disease, although specific genetic markers have not been definitively identified.
Certain autoimmune conditions, such as rheumatoid arthritis, systemic lupus erythematosus,

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Unicentric Castleman Disease

Initially, a thorough physical examination and medical history review are conducted. Blood tests may be ordered to check for abnormal protein levels and evaluate overall health. Imaging tests such as CT scans or MRIs can help visualize lymph node enlargement characteristic of the disease. A lymph node biopsy is often the definitive diagnostic method, where a small tissue sample is examined under a microscope for specific characteristics of Castleman disease. This comprehensive approach helps healthcare providers accurately diagnose Unicentric Castleman disease and plan appropriate treatment.

Blood tests to check for elevated levels of inflammatory markers and other abnormalities.
Imaging scans such as CT or MRI to visualize lymph nodes and other affected areas.
Lymph node biopsy to examine tissue samples for abnormal cell growth characteristic of Castleman disease.
Consultation with a hematologist or oncologist for specialized evaluation and treatment planning.
PET scan to assess the extent of disease involvement and help guide treatment decisions.

Treatment for Unicentric Castleman Disease

Treatment options for Unicentric Castleman disease typically focus on managing symptoms and controlling the abnormal immune response that characterizes this condition. The mainstay of treatment often involves surgical removal of the affected lymph node, which can provide a potential cure for some patients. In cases where surgery is not feasible or if the disease recurs, other approaches such as radiation therapy, corticosteroids, or immunosuppressive medications may be considered to help suppress inflammation and control symptoms. Regular monitoring by healthcare providers is essential to track disease progression and adjust treatment as needed to ensure the best possible outcomes for patients with Unicentric Castleman disease.

Unicentric Castleman disease, a rare disorder of the lymph nodes, can be treated through various approaches depending on the individual's condition. Treatment options for Unicentric Castleman disease commonly include surgical removal of the affected lymph node or nodes. This procedure aims to alleviate symptoms by eliminating the abnormal tissue causing the disease. In cases where surgery may not be suitable or sufficient, radiation therapy is another treatment modality used for Unicentric Castleman disease.
Radiation therapy targets the affected lymph node to reduce its size and control abnormal cell growth. Pharmacological treatments such as corticosteroids or immunosuppressants may also be prescribed to manage symptoms and reduce inflammation associated with Unicentric Castleman disease.

Find Our Specialists

Book Doctor Appointment

Name*

Mobile Number*

I agree to the Medicover Privacy Policy

International Patient Services

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

Are there specific signs that indicate Unicentric Castleman disease?

Enlarged lymph nodes and fatigue are common signs of Unicentric Castleman disease.

What are the recommended do's and don'ts for managing Unicentric Castleman disease?

Do seek medical guidance, monitor symptoms, and follow treatment plans. Don't delay seeking medical help or stop treatment without consulting a healthcare professional.

What are the potential complications of Unicentric Castleman disease?

Potential complications of Unicentric Castleman disease include anemia, infection, and the development of lymphoma.

What are the best ways to manage Unicentric Castleman disease?

Treatment options for Unicentric Castleman disease may include surgery to remove the affected lymph node or medications to reduce symptoms and control inflammation.